Findings

What do systematic reviews say?

3 questions · 3 findings · 2 reviews · Musculoskeletal

No studies found 1 · 33.3%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 66.7%Moderate 0 · 0%High 0 · 0%

Short‐term serious adverse events · people with rheumatoid arthritis

The review found no eligible studies for this question.

1 finding from 1 review

Tai Chi for rheumatoid arthritis 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Short‐term serious adverse events · patients with rheumatoid arthritis

Celecoxib showed no clear difference in short‐term serious adverse events compared with traditional NSAIDs (low certainty).

1 finding from 1 review

Celecoxib for rheumatoid arthritis 2017 · Cochrane Headline outcomes only
Peto OR 0.71 [0.39, 1.28]
5 studies · 2154 participants
Low

Short‐term serious adverse events · patients with rheumatoid arthritis

Celecoxib showed no clear difference in short‐term serious adverse events compared with placebo (low certainty).

1 finding from 1 review

Celecoxib for rheumatoid arthritis 2017 · Cochrane Headline outcomes only
Peto OR 0.87 [0.28, 2.69]
1 study · 706 participants
Low